by admin | May 17, 2018 | Uncategorized
Caring for Those Often Pushed Away by our Community Throughout the story of the life of Jesus, we are reminded that we are expected, as Followers, to care for the sick; to reach out to the unloved and the untouchable; to go places where we might not be expected to go.... by admin | May 10, 2018 | Uncategorized
We visited the new Syringe Exchange program in Chattanooga and were overwhelmed with the great start to this exciting new program, called STEP TN. We invite you to visit the website for this program (part of Cempa Community Care). Samaritan Ministry is a financial... by admin | May 10, 2018 | Uncategorized
POZ magazine issues weekly news alerts at the POZ News Desk. (see poz.com) and one recent post got our attention. They recently shared a great summary about HIV Basics that we would like to share with you. This comprehensive piece covers everything from transmission... 
by admin | May 10, 2018 | Uncategorized
The treatment landscape for HIV is always changing. Recently, we learned about two new GENERIC combination treatments, Simfi Lo, and Cimduo. (No, we didn’t make those names up.) As some HIV drugs are aging past their patent protection, we are seeing several become... 
by admin | May 18, 2017 | Uncategorized
Samaritan Ministry is a community leader providing opportunities for HIV testing in a variety of settings. The test that we use (OraQuick Advance Rapid HIV Antibody Test) provides a quick 20-minute turn-around with results provided by a trained HIV counselor. OraSure... 
by admin | Feb 23, 2017 | Uncategorized
A look at the State of HIV through the eyes of Samaritan Ministry… With the end of 2016, we are taking time to reflect on what we have seen in the course of a year in the HIV world, and as we are providing leadership and care for many of the most marginalized in our... 
by admin | Mar 3, 2016 | Uncategorized
Researchers have for the first time documented a case of an individual contracting HIV, a multi-drug resistant strain, while apparently adhering well to the daily regimen of Truvada as pre-exposure prophylaxis (PrEP). The scientists concluded that it is indeed... by admin | Mar 3, 2016 | Uncategorized
A long-acting injectable formulation of ViiV’s cabotegravir and Janssen’s Edurant (rilpivirine), dosed every four or eight weeks, is safe and generally well tolerated and suppresses HIV as well as a daily oral regimen in an ongoing trial. The companies intend to... 
by admin | Mar 3, 2016 | Uncategorized
The U.S. Food and Drug Administration has approved the single-tablet HIV treatment regimen Odefsey, which includes a new, safer version of tenofovir. The tablet is an updated version of Complera, swapping tenofovir alafenamide, or TAF, for tenofovir disoproxil... 
by admin | Jan 27, 2016 | Uncategorized
Thanks to many, many volunteers and scores of donors, we were able to end 2015 in very comfortable shape. We were able to minister to many and our financials are looking good for 2016. Between the middle of November and Christmas we were very busy with a variety of...